tirzepatide news 2025 FDA Says Compounded Must Exit the Market Eli Lilly's weight loss drug

MASH is a severe form of metabolic liver disease the progressive stage of fatty liver disease

While Ozempic itself is not officially approved by regulators for weight loss alone, its active ingredient and mechanism are identical to the weight-loss-approved version, making its off-label use of Ozempic a subject of much discussion and clinical application under strict medical supervision

The peptide is primarily studied for targeted lipolysis the breakdown of stored triglycerides as well as adipose tissue metabolism, body composition endpoints, and more recently chondrocyte and cartilage repair models

PlexusDx partners exclusively with licensed 503A compounding pharmacies that meet FDA standards and state pharmacy board requirements

This surprisingly long research timeline matters because it shows how GLP-1 science has matured

(-)-l-carnitine 8